Showing results (1421-1430 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|December 20, 2022
Effect of Early Bacillus Calmette-Guerin Vaccination of Pediatric Severe Combined Immunodeficiency Patients on the Outcome of Hematopoietic Stem Cell Transplantation Using a Reduced-Intensity Conditioning RegimenLeila Jafari, Amir Ali Hamidieh, Maryam Behfar, et al.Transplantation and Cellular Therapy|October 24, 2021
Dynamical Systems Modeling of Early-Term Immune Reconstitution with Different Antithymocyte Globulin Administration Schedules in Allogeneic Stem Cell TransplantationViktoriya Zelikson, Gary Simmons, Natasha Raman, et al.Transplantation and Cellular Therapy|October 20, 2021
Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic ThrombocytopeniaMaria Cancio, Kyle Hebert, Soyoung Kim, et al.Transplantation and Cellular Therapy|February 13, 2022
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact OutcomesMalika Kapadia, Leslie Lehmann, Jeffery Auletta, et al.Transplantation and Cellular Therapy|February 24, 2022
American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant RecipientsCarolyn D Alonso, Gabriela Maron, Mini Kamboj, et al.Transplantation and Cellular Therapy|February 1, 2022
Outcomes After Donor Lymphocyte Infusion in Patients With Hematological Malignancies: Donor Characteristics MatterJose Ros-Soto, John A Snowden, Richard Szydlo, et al.Transplantation and Cellular Therapy|February 3, 2022
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome PathogenesisKirsten M Williams, Steven Z Pavletic, Stephanie J Lee, et al.Transplantation and Cellular Therapy|February 8, 2022
Thrombospondin-1, Platelet Factor 4, and Galectin-1 Are Associated with Engraftment in Patients with Sickle Cell Disease who Underwent Haploidentical Hematopoietic Stem Cell TransplantationAhmad Shaikh, Purevdorj B Olkhanud, Arunakumar Gangaplara, et al.Transplantation and Cellular Therapy|February 8, 2022
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance TreatmentMarta Reinoso-Segura, Teresa Caballero-Velázquez, Pilar Herrera, et al.Transplantation and Cellular Therapy|October 17, 2021
Driving Out Chronic Lymphocytic Leukemia With CAR T CellsMohamed A Kharfan-Dabaja, Farah Yassine, Martha E Gadd, et al.Pageof 183